Aktis Oncology, Inc.
Ticker: 2035832
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 3.91+15.7% | 3.38+4.6% | 3.23+104.4% | 1.58-1.3% | 1.60+10.3% | 1.45 |
| Total Income | 3.91+15.7% | 3.38+4.6% | 3.23+104.4% | 1.58-1.3% | 1.60+10.3% | 1.45 |
| EXPENSES | ||||||
| Expenditure | 38.65+19.7% | 32.28+24.5% | 25.93+31.1% | 19.78-12.3% | 22.56+15.2% | 19.59 |
| PROFIT | ||||||
| Net Profit | -29.94-24.0% | -24.14-31.7% | -18.33-18.0% | -15.53+14.1% | -18.08-20.6% | -14.99 |
| KEY METRICS | ||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.54-22.7% | -0.44-15.8% | -0.38+98.0% | -19.18+14.3% | -22.39-20.4% | -18.60 |
Corporate Events
Board MeetingAKTS
202615Apr
Board Meeting
Glenn Gormley appointed to the Board of Directors of Aktis O…
SEC Filing ↗